| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.02 |